Management of Distinction

At CTMG, we believe in working as an extension of your practice &endash; a complete and complementary team. CTMG personnel are present throughout the entire trial process, from trial acquisition through trial closeout. While patients are seen in your office, CTMG maintains all regulatory and study-related materials in its offices, minimizing the disruption to your practice.

CTMG is a CIMPS (Clinical Investigator Management Process System) that provides the controlled systems, as well as experienced personnel, to busy physician offices at no charge to the physician. Unlike Clinical Research Organizations (CROs), which represent the interest of pharmaceutical companies to administrate various aspects of clinical trials, CTMG represents the interests of the physician as a business associate. While Site Management Organizations (SMOs) provide clinical setting and coordination support outside of the PI’s office, CTMG works with you in your own office environment.

Responsibilities and processes are clearly defined at an early stage. We make certain that deadlines are met, quality is maintained, training is appropriate, and prompt payment for services is received. A CTMG staff member is always on call as a point of contact for study patients.

How We Benefit the Physician (P.I.)

The benefits to the Principal Investigator of working with CTMG are:

  • Participation in clinical trials at no cost or use of office personnel resources
  • Minimal disruption to their core business – seeing patients
  • Pursuit of their medical interests without having to become an expert in all the non-medical aspects of clinical trial execution
  • The ability to offer cutting edge research to patients
  • Compensation for participating in meaningful research


How We Benefit the Sponsor

The benefits to the Sponsor of working with CTMG-assisted Principal Investigators:

  • One point of communication for multiple PI sites performing the same trial
  • Trial procedures performed using controlled auditable processes
  • Rapid recruitment for trials through pre-identification of patients
  • Appropriate and adequate patient populations are ensured through CTMG’s pre-qualification of PI sites